Technical Analysis for CARA - Cara Therapeutics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Historical CARA trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Stochastic Reached Overbought | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Crossed Above 200 DMA | Bullish | 2.46% | |
| 180 Bullish Setup | Bullish Swing Setup | 2.46% | |
| Fell Below 200 DMA | Bearish | 4.41% | |
| 200 DMA Support | Bullish | 2.88% | |
| Upper Bollinger Band Walk | Strength | 2.88% | |
| Inside Day | Range Contraction | 2.88% | |
| Crossed Above 200 DMA | Bullish | 1.27% | |
| Upper Bollinger Band Walk | Strength | 1.27% |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/11/2020
- Sector: Healthcare
- Industry: Biotechnology
Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat pain. Its products include intravenous CR845 that has completed Phase II clinical trials for the treatment of acute postoperative pain in adult patients; Oral CR845, which is in Phase I clinical trials to treat acute and chronic pain; and CR701 that is in preclinical trials for treating neuropathic and inflammatory pain. The company was founded in 2004 and is based in Shelton, Connecticut.
Chemistry Biopharmaceutical Health Pain Clinical Trial Amines Piperidines Mesoblast
Chemistry Biopharmaceutical Health Pain Clinical Trial Amines Piperidines Mesoblast
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 27.55 |
| 52 Week Low | 8.88 |
| Average Volume | 548,401 |
| 200-Day Moving Average | 16.86 |
| 50-Day Moving Average | 15.84 |
| 20-Day Moving Average | 16.45 |
| 10-Day Moving Average | 17.15 |
| Average True Range | 0.85 |
| ADX | 12.2 |
| +DI | 23.32 |
| -DI | 14.75 |
| Chandelier Exit (Long, 3 ATRs ) | 15.44 |
| Chandelier Exit (Short, 3 ATRs ) | 17.24 |
| Upper Bollinger Band | 18.08 |
| Lower Bollinger Band | 14.83 |
| Percent B (%b) | 0.83 |
| BandWidth | 19.76 |
| MACD Line | 0.50 |
| MACD Signal Line | 0.41 |
| MACD Histogram | 0.0848 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 18.63 | ||||
| Resistance 3 (R3) | 18.66 | 18.32 | 18.44 | ||
| Resistance 2 (R2) | 18.32 | 18.04 | 18.30 | 18.38 | |
| Resistance 1 (R1) | 17.92 | 17.86 | 17.75 | 17.89 | 18.32 |
| Pivot Point | 17.58 | 17.58 | 17.49 | 17.56 | 17.58 |
| Support 1 (S1) | 17.18 | 17.30 | 17.01 | 17.15 | 16.72 |
| Support 2 (S2) | 16.84 | 17.12 | 16.83 | 16.66 | |
| Support 3 (S3) | 16.44 | 16.84 | 16.60 | ||
| Support 4 (S4) | 16.41 |
